Andrew J Pollard Selected Research

ChAdOx1 nCoV-19

11/2022	Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
1/2022	CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination.
12/2021	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
11/2021	AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific TH1 response with a diverse TCR repertoire.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
7/2021	T-cell mediated immunity after AZD1222 vaccination: A polyfunctional spike-specific Th1 response with a diverse TCR repertoire.
1/2021	Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
1/2021	Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
1/2021	Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Pollard Research Topics

Disease

86	Infections 12/2022 - 06/2002
57	Typhoid Fever (Typhoid) 11/2022 - 06/2007
27	Meningococcal Infections 12/2022 - 02/2003
24	COVID-19 12/2022 - 01/2020
21	Diphtheria 01/2022 - 04/2005
17	Fever (Fevers) 11/2022 - 09/2010
16	Whooping Cough (Pertussis) 01/2022 - 04/2005
14	Bacterial Infections (Bacterial Infection) 07/2022 - 12/2005
14	Tetanus 01/2022 - 04/2005
11	Communicable Diseases (Infectious Diseases) 01/2022 - 05/2011
11	Pneumococcal Infections 01/2022 - 01/2007
11	Poliomyelitis (Polio) 01/2020 - 04/2005
10	Measles 12/2022 - 06/2013
9	Human Influenza (Influenza) 01/2021 - 03/2012
8	Mumps 12/2022 - 06/2013
8	Pain (Aches) 11/2022 - 01/2008
8	Meningitis 01/2022 - 03/2010
7	Hepatitis B 01/2021 - 03/2008
6	Rubella (German Measles) 01/2022 - 06/2015
6	Vaccinia 10/2021 - 04/2016
5	Virus Diseases (Viral Diseases) 01/2022 - 08/2016
5	Pharyngitis (Sore Throat) 01/2021 - 09/2010
5	Bacterial Meningitis 12/2018 - 01/2009
4	Headache (Headaches) 12/2021 - 08/2006
4	Sepsis (Septicemia) 01/2019 - 11/2010
4	Disease Susceptibility (Diathesis) 01/2018 - 10/2004
4	Bacteremia 01/2017 - 05/2014
3	Japanese Encephalitis 11/2022 - 10/2017
3	Salmonella Infections (Salmonellosis) 01/2020 - 03/2013
3	Lymphadenitis (Adenitis) 12/2019 - 09/2010
3	Aphthous Stomatitis (Aphthous Ulcer) 12/2019 - 09/2010
3	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 01/2017
3	Inflammation (Inflammations) 09/2015 - 05/2010
2	Vaccine-Preventable Diseases 01/2022 - 01/2020
2	Paratyphoid Fever 12/2021 - 01/2017
2	Asymptomatic Infections 11/2021 - 01/2018
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Ebola Hemorrhagic Fever 01/2021 - 01/2020
2	Myalgia 01/2021 - 12/2014
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2020 - 01/2020
2	Respiratory Syncytial Virus Infections 10/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

156	VaccinesIBA 12/2022 - 06/2002
65	Conjugate VaccinesIBA 12/2022 - 04/2005
27	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2004
25	AntigensIBA 01/2022 - 01/2006
24	Polysaccharides (Glycans)IBA 11/2021 - 02/2003
16	AntibodiesIBA 01/2022 - 04/2005
15	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 03/2010
14	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 11/2022 - 04/2005
12	ChAdOx1 nCoV-19IBA 11/2022 - 01/2020
11	Immunoglobulin G (IgG)IBA 01/2022 - 12/2010
10	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 12/2021 - 06/2015
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 05/2010
6	TCVSIBA 11/2022 - 10/2018
6	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 03/2012
5	MenACWYIBA 12/2022 - 01/2008
5	FluoroquinolonesIBA 01/2022 - 01/2018
5	CytokinesIBA 01/2022 - 05/2004
5	GlycoconjugatesIBA 12/2021 - 09/2006
5	Glycoproteins (Glycoprotein)IBA 01/2021 - 04/2016
5	Pharmaceutical PreparationsIBA 10/2019 - 04/2008
5	Capsules (Microcapsules)IBA 08/2012 - 02/2003
4	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022 - 03/2016
4	COVID-19 VaccinesIBA 01/2022 - 01/2020
4	Biological ProductsIBA 01/2021 - 03/2016
4	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2020 - 11/2016
3	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2017
3	Carrier Proteins (Binding Protein)IBA 10/2021 - 01/2016
3	Nucleic AcidsIBA 10/2021 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2004
3	Neutralizing AntibodiesIBA 01/2021 - 04/2016
3	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2021 - 04/2016
3	NucleoproteinsIBA 01/2021 - 06/2012
3	C-Reactive ProteinIBA 01/2021 - 03/2015
3	Immunoglobulin A (IgA)IBA 01/2019 - 01/2015
3	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2015
3	EnzymesIBA 05/2017 - 06/2012
3	LipopolysaccharidesIBA 01/2017 - 05/2014
3	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 05/2014 - 03/2009
3	Phosphates (Orthophosphate)IBA 01/2014 - 04/2005
2	EpitopesIBA 01/2022 - 01/2018
2	4CMenB vaccineIBA 01/2022 - 04/2015
2	Combined VaccinesIBA 12/2021 - 02/2015
2	InterferonsIBA 01/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2016
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2012
2	FlagellinIBA 01/2017 - 05/2014
2	pertactin FDA Link 01/2017 - 10/2012
2	Immunoglobulin M (IgM)IBA 01/2017 - 01/2015
2	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 10/2012
2	Amino Acids FDA Link 01/2017 - 01/2016

Therapy/Procedure

8	Therapeutics 01/2022 - 05/2004
3	Tonsillectomy 12/2019 - 09/2010
3	Critical Care (Surgical Intensive Care) 01/2019 - 08/2016
3	Length of Stay 12/2018 - 03/2015
2	Injections 06/2021 - 01/2021